Delivery Order SPE2DB24D3015-SPE2DB25FFZDB
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $77,949.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 10 milliliter vials of the vaccine TYPHIM VI 25 MCG/0.5 ML, with an ultimate completion date of April 21, 2025. This contract is not set-aside and was awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,617.86 contract is for the provision of 4,563,955,495 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This federal contract award, valued at $9,363.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,363,711 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract is a firm fixed-price Delivery Order with an ultimate completion date of August 7, 2024. There was no set-aside used for this award. AmerisourceBergen, as the prime contractor, will be responsible for supplying these critical...
The U.S. Defense Logistics Agency (DLA) awarded a $7,451.67 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,956,103 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $3,846.38, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. The contract covers the procurement of 4,558,548,341 units of the vaccine TYPHIM VI 25 MCG/0.5...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,502.31 firm-fixed-price delivery order is for the supply of 4,563,458,750 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,565,505,318 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract, valued at $18,726.20, is a firm fixed-price delivery order with an ultimate completion date of August 20, 2024. Amerisourcebergen, through its Corporate Office Division, will supply this critical vaccine to support the healthcare needs of military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,670,234 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $2,879.76. The contract has a Firm Fixed Price pricing type and is a Delivery Order. The contract has an ultimate completion date of March 24, 2025. The contract does not have a set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $18,924.08, is for the delivery of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. It is a firm fixed-price delivery order contract with a completion date of December 12, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for $56,178.60 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a type of vaccine. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...